Simon Ingate
Engagement Manager (Consulting) at Axian Consulting Ltd- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
Spanish Full professional proficiency
Topline Score
Bio
Credentials
-
PhD
-
Experience
-
Axian Consulting Ltd
-
United Kingdom
-
Business Consulting and Services
-
1 - 100 Employee
-
Engagement Manager (Consulting)
-
Jan 2021 - Present
Axian Consulting Ltd. is a spinout from Huron which concentrates on the delivery of Digital approaches to patient care. My main interests are in the development of patient centric information sources that help patients understand the appropriate and safe use of their medicines. Axian Consulting Ltd. is a spinout from Huron which concentrates on the delivery of Digital approaches to patient care. My main interests are in the development of patient centric information sources that help patients understand the appropriate and safe use of their medicines.
-
-
-
-
Principal Consultant/ SafetyGauge Product Manager
-
2012 - Jan 2021
Effectiveness evaluation of drug risk minimisation measures (RMMS) is key to good pharmacovigilance practice. SafetyGauge is a platform for delivering sophisticated interactive RMMs allowing healthcare professionals to educate, assess and communicate risks with their patients. Interactive RMMs provide data for assessing their utilisation across markets, user behaviours and deliver real-time measurements of their effectiveness. http://www.pwinformatics.com/safetygauge/ Effectiveness evaluation of drug risk minimisation measures (RMMS) is key to good pharmacovigilance practice. SafetyGauge is a platform for delivering sophisticated interactive RMMs allowing healthcare professionals to educate, assess and communicate risks with their patients. Interactive RMMs provide data for assessing their utilisation across markets, user behaviours and deliver real-time measurements of their effectiveness. http://www.pwinformatics.com/safetygauge/
-
-
-
-
Senior Consultant
-
Jan 2005 - Jan 2021
Consulting to pharma industry in areas such as: - Regulatory and drug risk management planning/ risk minimisation Evaluating the effectiveness of risk minimisation through the use of innovative web-based technologies (real-time behaviour capture). Development of PW's SafetyGauge platform. Collection of real-world outcomes data (e.g. patient reported outcomes; some work on the development of guidance for use of PROs in drug safety (recently published in Drug Safety Journal) - some… Show more Consulting to pharma industry in areas such as: - Regulatory and drug risk management planning/ risk minimisation Evaluating the effectiveness of risk minimisation through the use of innovative web-based technologies (real-time behaviour capture). Development of PW's SafetyGauge platform. Collection of real-world outcomes data (e.g. patient reported outcomes; some work on the development of guidance for use of PROs in drug safety (recently published in Drug Safety Journal) - some collaboration with PatientsLikeMe - Regulatory challenge panels - Market Access and HTA evaluations (NICE and DoH) - Recent projects - development of software to support patient access scheme management and reporting - Product portfolio analysis (Mature Product portfolio rationalisation) - Business process redesign Show less Consulting to pharma industry in areas such as: - Regulatory and drug risk management planning/ risk minimisation Evaluating the effectiveness of risk minimisation through the use of innovative web-based technologies (real-time behaviour capture). Development of PW's SafetyGauge platform. Collection of real-world outcomes data (e.g. patient reported outcomes; some work on the development of guidance for use of PROs in drug safety (recently published in Drug Safety Journal) - some… Show more Consulting to pharma industry in areas such as: - Regulatory and drug risk management planning/ risk minimisation Evaluating the effectiveness of risk minimisation through the use of innovative web-based technologies (real-time behaviour capture). Development of PW's SafetyGauge platform. Collection of real-world outcomes data (e.g. patient reported outcomes; some work on the development of guidance for use of PROs in drug safety (recently published in Drug Safety Journal) - some collaboration with PatientsLikeMe - Regulatory challenge panels - Market Access and HTA evaluations (NICE and DoH) - Recent projects - development of software to support patient access scheme management and reporting - Product portfolio analysis (Mature Product portfolio rationalisation) - Business process redesign Show less
-
-
-
Accelrys
-
Software Development
-
Business Developement Consultant
-
Jun 2000 - 2003
Helped sales bring in complex software development consulting projects. Acted as programme manager (business contact) for incoming and projects that were being delivered with regular liaison with clients and the project managers. Worked on developing bespoke client software into marketable products. Lead RFP reply teams for major bids (largest project proposed $2.5M). Helped sales bring in complex software development consulting projects. Acted as programme manager (business contact) for incoming and projects that were being delivered with regular liaison with clients and the project managers. Worked on developing bespoke client software into marketable products. Lead RFP reply teams for major bids (largest project proposed $2.5M).
-
-
-
Storage Technology Ltd
-
United Kingdom
-
Pharmaceutical Services Consultant
-
Oct 1998 - Nov 1999
Worked with sales teams to develop business within the pharmaceutical industry (large multi-terabyte data archiving and management systems). First sales project worked on was a large archive for SmithKline Beecham (value £10M). Sold archive systems into the medical market (storage for PACS systems for Medical Imaging). Worked with sales teams to develop business within the pharmaceutical industry (large multi-terabyte data archiving and management systems). First sales project worked on was a large archive for SmithKline Beecham (value £10M). Sold archive systems into the medical market (storage for PACS systems for Medical Imaging).
-
-
-
CSIC
-
Research
-
700 & Above Employee
-
Post Doctoral Research Scientist
-
Jan 1993 - Jul 1998
Worked on the chemical synthesis of molecules targeted at the reproduction of the AIDS virus - Inhibitors of the HIV-1 reverse transcriptase inhibitors. Supervised PhD students, one of whom discovered a new class of HIV-1-RT inhibitors called the TTDs. Published 15 articles and one review in peer reviewed journals (Antiviral Research, Nucleotides and Nucleosides, Journal of Medicinal Chemistry, Tetrahedron etc.). Worked on novel sugar and heterocyclic chemistry synthesis. Learnt fluent Spanish,… Show more Worked on the chemical synthesis of molecules targeted at the reproduction of the AIDS virus - Inhibitors of the HIV-1 reverse transcriptase inhibitors. Supervised PhD students, one of whom discovered a new class of HIV-1-RT inhibitors called the TTDs. Published 15 articles and one review in peer reviewed journals (Antiviral Research, Nucleotides and Nucleosides, Journal of Medicinal Chemistry, Tetrahedron etc.). Worked on novel sugar and heterocyclic chemistry synthesis. Learnt fluent Spanish, met a lot of fantastic people and had lots of fun. Show less Worked on the chemical synthesis of molecules targeted at the reproduction of the AIDS virus - Inhibitors of the HIV-1 reverse transcriptase inhibitors. Supervised PhD students, one of whom discovered a new class of HIV-1-RT inhibitors called the TTDs. Published 15 articles and one review in peer reviewed journals (Antiviral Research, Nucleotides and Nucleosides, Journal of Medicinal Chemistry, Tetrahedron etc.). Worked on novel sugar and heterocyclic chemistry synthesis. Learnt fluent Spanish,… Show more Worked on the chemical synthesis of molecules targeted at the reproduction of the AIDS virus - Inhibitors of the HIV-1 reverse transcriptase inhibitors. Supervised PhD students, one of whom discovered a new class of HIV-1-RT inhibitors called the TTDs. Published 15 articles and one review in peer reviewed journals (Antiviral Research, Nucleotides and Nucleosides, Journal of Medicinal Chemistry, Tetrahedron etc.). Worked on novel sugar and heterocyclic chemistry synthesis. Learnt fluent Spanish, met a lot of fantastic people and had lots of fun. Show less
-
-
Education
-
1988 - 1992
University of Portsmouth
PhD, Synthetic and Physical Chemistry -
1984 - 1988
University of Portsmouth
BSc, Applied Chemistry
Community
